Skip to main content

Table 3 Resistance comparisons of H. pylori isolates from patients with different genders, ages, and endoscopic findings

From: Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China

Antibiotic

Gender (n, %)

P

Age (n, %)

P

Endoscopic findings (n, %)

P

Male

(n = 74)

Female

(n = 79)

18–40

(n = 17)

41–55

(n = 108)

 ≥ 56

(n = 28)

NPU

(n = 108)

PU

(n = 45)

Clarithromycin

17 (22.9)

25 (31.6)

0.193

3 (17.6)

29 (27.4)

10 (35.7)

0.415

33 (31.1)

9 (20.0)

0.163

Levofloxacin

16 (21.6)

32 (40.5)

0.012 *

7 (41.1)

34 (31.5)

7 (25.0)

0.525

37 (34.3)

11 (24.4)

0.233

Metronidazole

62 (83.7)

70 (88.6)

0.386

14 (82.3)

92 (85.2)

26 (92.8)

0.508

95 (88.0)

37 (82.2)

0.347

Amoxicillin

7 (9.5)

17 (21.5)

0.040*

2 (11.7)

17 (15.7)

5 (17.8)

0.862

15 (13.9)

9 (20.0)

0.344

Rifampicin

54 (72.9)

58 (73.4)

0.951

12 (70.5)

78 (72.2)

22 (78.5)

0.770

76 (70.4)

36 (80.0)

0.220

  1. NPU Non-peptic ulcer, PU Peptic ulcer